Evidence map›Paper›PMID 40657267›Full record

ReviewIJTLD open2025

TB elimination in Southern Africa: overview and critical reflection.

J Boffa, D Vambe, C Khosa, B José, N Ndjeka, T Nkomo, A W Kay, A M Mandalakas, L Mvusi, S V Omar and 4 more

Abstract readReview
In one paragraph

Review in IJTLD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

J BoffaTB Think Tank, The Aurum Institute, Johannesburg, South Africa.
D VambeGlobal TB Program, Department of Pediatrics, Baylor College of Medicine, Houston USA.
C KhosaInstitute Nacional de Saúde, Marracuene, Mozambique.
B JoséNational TB Control Programme, Maputo, Mozambique.
N NdjekaTB Cluster, National Department of Health, Pretoria, South Africa.
T NkomoNational TB Control Programme, Eswatini.
A W KayGlobal TB Program, Department of Pediatrics, Baylor College of Medicine, Houston USA.
A M MandalakasGlobal TB Program, Department of Pediatrics, Baylor College of Medicine, Houston USA.
L MvusiTB Cluster, National Department of Health, Pretoria, South Africa.
S V OmarCentre for Tuberculosis, National and WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases a division of the National Health Laboratory Service, Johannesburg, South Africa.
S ThiNational TB Control Programme, Eswatini.
K VelenFIND, Geneva, Switzerland.
S CharalambousThe Aurum Institute, Johannesburg, South Africa.
M X RangakaInstitute for Global Health and MRC Clinical Trials Unit, University College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite significant progress, TB remains a major public health challenge in Southern Africa. We highlight the key initiatives in Eswatini, Mozambique and South Africa, which have implemented various interventions, including systematic TB screening, TB preventive treatment, targeted next-generation sequencing, targeted universal testing, and shorter drug-resistant and paediatric TB regimens. We also identify the key challenges, such as inconsistent drug access, increasing drug resistance and limited healthcare capacity, which continue to affect progress. Health systems must also balance TB care with broader healthcare priorities, and the integration of TB care into existing services requires further investment in outreach, treatment support and training. Identifying and treating missing people with TB, diagnosing TB in children, and improving treatment adherence remain critical areas requiring enhanced support and resources. While new diagnostic tools and treatments offer promise, their high costs and labour demands present barriers to routine implementation. Successful TB elimination will depend on simple, low-cost prevention, testing and treatment options, tailored to each country's specific needs. All of which will require sustained political commitment, innovation and strategic investments in health system strengthening and community-based care.

Indexed as

Eswatiniimplementation challengesMozambiquepublic healthSouth Africatuberculosis

Identifiers

PMID40657267
PMCPMC12248405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.